Genomics & Proteomics

The Genomics & Proteomics category features high-throughput instrumentation essential for DNA, RNA, and protein analysis. These tools are critical in molecular biology, cancer research, personalized medicine, biomarker discovery, and systems biology, allowing researchers to unravel the complexities of gene expression, genetic variation, and protein dynamics in health and disease. DNA Sequencers are powerful platforms used for whole-genome and targeted sequencing, enabling researchers to decode DNA at base-pair resolution. Applications include cancer genomics, hereditary disease research, pathogen detection, and population genetics. Advanced next-generation sequencers (NGS) support high-throughput analysis, multiplexing, and real-time data output, making them ideal for labs conducting large-scale genomic studies. DNA/RNA Analyzers are designed for the quantification and integrity assessment of nucleic acids. These instruments use microfluidic or capillary electrophoresis systems to assess RNA integrity numbers (RIN), quantify low-abundance samples, and facilitate library preparation for sequencing. They are indispensable for transcriptomics, single-cell genomics, and RNA-seq workflows, where sample quality determines experimental success. Protein Quantification Systems are used to determine protein concentration, purity, and biomarker abundance. These systems are crucial in drug development, proteomics research, and clinical diagnostics. Techniques include UV absorbance, BCA and Bradford assays, and label-free quantification methods. Protein data is essential for understanding disease progression, drug response, and therapeutic target validation. Array Scanners are used in gene expression profiling, SNP genotyping, copy number variation studies, and protein microarray analysis. They are especially valuable in clinical research, agricultural genomics, and personalized medicine, offering high-density data output and fluorescence-based detection. DNA Shearing Machines mechanically or enzymatically fragment nucleic acids into defined sizes, a crucial step in next-generation sequencing (NGS) and CRISPR genome editing. They provide consistent fragment lengths for library construction and downstream amplification. At Wasteless Bio, we offer a wide range of surplus genomic and proteomic systems, complete with detailed specifications and cost-saving advantages—supporting advanced research and sustainable procurement.